“Reaching people living with HIV with care, treatment and support to improve their longevity and quality of life, and to prevent new infections (a concept known as Treatment as Prevention, or TasP® ) has helped bring the HIV epidemic under control in British Columbia. TasP is a strategy many countries around the world have adopted. Now, the Canadian expert who developed TasP® is looking to transfer the success of this initiative to stamp out another global epidemic: hepatitis C.
During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.
During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
